InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.235 0.01 (4.44%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$141 Application for quotation of securities - DXB 2 Jan 2024 9:02AM $0.205 $0.235 risen by 14.63%
$141 Application for quotation of securities - DXB 29 Dec 2023 10:04AM $0.200 $0.235 risen by 17.50%
$141 Change of Director's Interest Notice - NW 1 Dec 2023 11:09AM $0.145 $0.235 risen by 62.07%
$141 Initial Director's Interest Notice - MD 1 Dec 2023 10:59AM $0.145 $0.235 risen by 62.07%
$141 Notification regarding unquoted securities - DXB 1 Dec 2023 10:25AM $0.138 $0.235 risen by 70.91%
$141 ACTION3 IND Approved in China 28 Nov 2023 9:03AM $0.140 $0.235 risen by 67.86%
$141 Results of Meeting 21 Nov 2023 2:48PM $0.145 $0.235 risen by 62.07%
$141 AGM Presentation 21 Nov 2023 11:55AM $0.135 $0.235 risen by 74.07%
$141 Dimerix Announces the Appointment of Non-Executive Chairman 20 Nov 2023 8:59AM $0.140 $0.235 risen by 67.86%
$141 Application for quotation of securities - DXB 14 Nov 2023 3:16PM $0.155 $0.235 risen by 51.61%
$141 Application for quotation of securities - DXB 8 Nov 2023 4:30PM $0.170 $0.235 risen by 38.24%
$141 Change of Director's Interest Notices - NW 6 Nov 2023 3:17PM $0.180 $0.235 risen by 30.56%
$141 Dimerix Receives Initial Upfront Payment from Advanz Pharma 6 Nov 2023 9:18AM $0.175 $0.235 risen by 34.29%
$141 Application for quotation of securities - DXB 3 Nov 2023 9:29AM $0.190 $0.235 risen by 23.68%
$141 Notification of cessation of securities - DXB 31 Oct 2023 1:22PM $0.180 $0.235 risen by 30.56%
$141 Quarterly Appendix 4C and Activities Report 30 Oct 2023 9:09AM $0.160 $0.235 risen by 46.88%
$141 Notification of cessation of securities - DXB 25 Oct 2023 11:12AM $0.145 $0.235 risen by 62.07%
$141 Letter to Shareholders, Notice of AGM & Proxy Form 24 Oct 2023 8:46AM $0.145 $0.235 risen by 62.07%
$141 Dimerix Appoints Chief Medical Officer 23 Oct 2023 8:42AM $0.135 $0.235 risen by 74.07%
$141 Application for quotation of securities - DXB 20 Oct 2023 11:15AM $0.130 $0.235 risen by 80.77%
$141 Application for quotation of securities - DXB 17 Oct 2023 11:00AM $0.175 $0.235 risen by 34.29%
$141 Application for quotation of securities - DXB 16 Oct 2023 10:26AM $0.165 $0.235 risen by 42.42%
$141 Application for quotation of securities - DXB 9 Oct 2023 11:14AM $0.180 $0.235 risen by 30.56%
$141 Investor Webinar and Presentation 5 Oct 2023 8:51AM $0.061 $0.235 risen by 285.25%
$141 Dimerix Announces License Agreement for EU, Canada, ANZ 5 Oct 2023 8:43AM $0.061 $0.235 risen by 285.25%

251 - 275 of 739 results

Page 11 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.